Mediglen Pharmaceuticals Private Limited

Mediglen Pharmaceuticals Private Limited - chemicals in Delhi, India. FY 2026 financials & compliance.
CIN U24290DL2021PTC389513 Incorporated 09 November 2021 ROC Delhi HQ Delhi, India
Active Private Limited Company chemicals MSME · Micro
Revenue · FY 2023
₹2,120
▼ 51% YoY
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2023
Balance sheet date
Last AGM
16 Aug 2023
Annual general meeting

About Mediglen Pharmaceuticals Private Limited

Data last updated:

Mediglen Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 November 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC389513. Its GSTIN is 10AAPCM1578B1ZR (Bihar).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Mayank Kumar and Rakesh Kumar.

Its last annual general meeting (AGM) was held on 16 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No – 12 13 & 14 Kh No – 20/21 & 21 F/F Ranaji Encl Ph 2 Nangali Dariy, Delhi, India – 110043.

Mediglen Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0021295).

Company details

CIN U24290DL2021PTC389513
Registration Number 389513
Incorporation Date 09 November 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0021295

Recognitions & Rankings of Mediglen Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-DL-10-0021295

Contact details

Mediglen Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No – 12 13 & 14 Kh No – 20/21 & 21 F/F Ranaji Encl Ph 2 Nangali Dariy, Delhi, India – 110043
  • Industry
    Chemicals, Manufacturing, Other Chemical Product

To see the full contact details of Mediglen Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Mediglen Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mediglen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Mediglen Pharmaceuticals Private Limited, buy the company report.

Financials of Mediglen Pharmaceuticals Private Limited

FY 2023 filings available

Mediglen Pharmaceuticals Private Limited reported revenue of ₹2,120 (down 51% YoY) for FY 2023.

Revenue · FY 2023
₹2,120 ▼ 51%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 51%

Revenue fell 51% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mediglen Pharmaceuticals Private Limited, buy the company report.

Board of directors of Mediglen Pharmaceuticals Private Limited

Mediglen Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Mayank KumarDirector09 Nov 20215 Years 0 MonthsCurrent
Rakesh KumarDirector09 Nov 20215 Years 0 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mediglen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Mediglen Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.

Active EPFO establishments
1

GST

Mediglen Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AAPCM1578B1ZRBiharActive26 Nov 2021

To see the full GST registrations and return filing status of Mediglen Pharmaceuticals Private Limited, buy the company report.

Recent activity

Mediglen Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Mayank Kumar was appointed as Director on 09 Nov 2021.

AGM
Mediglen Pharmaceuticals Private Limited last Annual general meeting of members was held on 16 Aug 2023 as per latest MCA records.
Filing
Mediglen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi I.
Appointed
Mayank Kumar was appointed as Director.
Appointed
Rakesh Kumar was appointed as Director.
Incorporation
09 Nov 2021
Mediglen Pharmaceuticals Private Limited was registered on 09 Nov 2021 with Roc Delhi I & aged 5 years 7 days as per MCA records.

Frequently asked questions

Mediglen Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 November 2021 (5+ years old) and is registered under CIN U24290DL2021PTC389513.

Mediglen Pharmaceuticals has 2 current directors:

The latest financial statements of Mediglen Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 16 August 2023. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Mediglen Pharmaceuticals is 10AAPCM1578B1ZR, registered in Bihar.

The CIN (Corporate Identification Number) of Mediglen Pharmaceuticals is U24290DL2021PTC389513. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mediglen Pharmaceuticals was incorporated on 09 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.

Mayank Kumar was appointed as Director on 09 Nov 2021. Rakesh Kumar was appointed as Director on 09 Nov 2021.

Yes, Mediglen Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0021295).

The registered office of Mediglen Pharmaceuticals is at Plot No – 12 13 & 14 Kh No – 2021 & 21 FF Ranaji Encl Ph 2 Nangali Dariy, Delhi, India – 110043.

Mediglen Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.